Free. Unsubscribe any time.
NewAmsterdam Pharma Co N.V. (NAMS)
NewAmsterdam Pharma Co N.V. filed 15 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 35 transactions and 1,325,341 shares. 15 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 8 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-08-25, came 34 days after the one before it (2026-07-22) and reports 3 transactions against 7 in the filing before it.
- The sales it reports total 125,000 shares, 20,000 more than the 105,000 in the filing before it.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 15 filings on file run from 2025-01-02 to 2026-08-25, and state no plan adoption date.
Trades in NewAmsterdam Pharma Co N.V. 35
- ForGrowth NAP B.V. — 2024-12-30 · S · 29,846 shares
- Kling Douglas F — 2025-01-27 · S · 80,359 shares
- Kling Douglas F — 2025-01-27 · S · 23,815 shares
- Somaiya Mayur Ian — 2025-01-27 · S · 33,679 shares
- Somaiya Mayur Ian — 2025-01-27 · S · 13,304 shares
- Kling Douglas F — 2025-01-28 · S · 20,237 shares
- Kling Douglas F — 2025-01-28 · S · 5,148 shares
- Somaiya Mayur Ian — 2025-01-28 · S · 11,495 shares
- Somaiya Mayur Ian — 2025-01-28 · S · 3,405 shares
- Kling Douglas F — 2025-01-29 · S · 56,863 shares
- Kling Douglas F — 2025-01-30 · S · 4,664 shares
- Kling Douglas F — 2025-01-30 · S · 8,914 shares
Adoption dates in NewAmsterdam Pharma Co N.V. 0
Results prints in NewAmsterdam Pharma Co N.V. 8
- 2025-02-26
- 2025-05-08
- 2025-08-06
- 2025-11-05
- 2026-01-09
- 2026-02-18
- 2026-05-07
- 2026-08-05
Trades before a print in NewAmsterdam Pharma Co N.V. 0
- 7 days before the 2025-02-26 print — 2025-02-19 · S · Kling Douglas F · 9,218 shares
- 8 days before the 2025-02-26 print — 2025-02-18 · S · Kling Douglas F · 90,782 shares
- 16 days before the 2026-08-05 print — 2026-07-20 · S · Kooij Louise Frederika · 70,200 shares
- 16 days before the 2026-08-05 print — 2026-07-20 · S · Kooij Louise Frederika · 31,885 shares
- 16 days before the 2026-08-05 print — 2026-07-20 · S · Kooij Louise Frederika · 2,915 shares
- 21 days before the 2025-08-06 print — 2025-07-16 · S · Kling Douglas F · 51,043 shares
- 22 days before the 2025-08-06 print — 2025-07-15 · S · Kling Douglas F · 44,025 shares
- 22 days before the 2025-08-06 print — 2025-07-15 · S · Kling Douglas F · 3,544 shares
- 23 days before the 2025-05-08 print — 2025-04-15 · S · Kling Douglas F · 99,090 shares
- 23 days before the 2025-05-08 print — 2025-04-15 · S · Kling Douglas F · 910 shares
- 27 days before the 2025-02-26 print — 2025-01-30 · S · Kling Douglas F · 4,664 shares
- 27 days before the 2025-02-26 print — 2025-01-30 · S · Kling Douglas F · 8,914 shares
Interval to NewAmsterdam Pharma Co N.V.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 2within 10 days
- 7shortest, days
- 1no later print
- Kling Douglas F 2025-02-18 · S · 8 days before the 2025-02-26 print · Chief Operating Officer
- Kling Douglas F 2025-02-19 · S · 7 days before the 2025-02-26 print · Chief Operating Officer
Reported results dates on file
- 2025-02-26
- 2025-05-08
- 2025-08-06
- 2025-11-05
- 2026-01-09
- 2026-02-18
- 2026-05-07
- 2026-08-05
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.